• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Moderna Inc (NQ: MRNA )

    69.86 -2.13 (-2.96%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,278,888
    Open 72.19
    Bid (Size) 70.05 (8)
    Ask (Size) 70.30 (6)
    Prev. Close 71.99
    Today's Range 69.82 - 73.35
    52wk Range 62.55 - 170.47
    Shares Outstanding 384,000,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Moderna, Inc. REMINDER – MRNA Stockholders Should Contact Robbins LLP for Information About the Moderna, Inc. Class Action and Pending Lead Plaintiff Deadline
    From Robbins LLP
    Via GlobeNewswire
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga

    Performance

    YTD
    -37.90%
    -37.90%
    1 Month
    -22.34%
    -22.34%
    3 Month
    -48.02%
    -48.02%
    6 Month
    -32.23%
    -32.23%
    1 Year
    -34.55%
    -34.55%

    More News

    Read More
    Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse
    Via Benzinga
    16 Analysts Have This To Say About Moderna
    Via Benzinga
    Here's How Much You Would Have Made Owning Moderna Stock In The Last 5 Years
    Via Benzinga
    Tradepulse Power Inflow Alert: Moderna Inc. Rises 8.9% On The Trading Day
    Via Benzinga
    Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
    Via The Motley Fool
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    S&P 500 Briefly Hits Record High Just Ahead Of Fed Rate Cut, Extends 7-Day Winning Streak: Tuesday's Top 5 Gainers
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Momentum Investing Gives You An Edge, Until It Doesn’t
    Via Talk Markets
    Small Caps, Bitcoin Rally As Traders Await Fed Rate Cut; Treasury Yields, US Dollar Tick Up On Strong Retail Sales: What's Driving Markets Tuesday?
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    What's Going On With Moderna Shares Tuesday?
    Via Benzinga
    Exposures COVID-19
    Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older
    Via ACCESSWIRE
    MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
    Via Benzinga
    Exposures COVID-19
    Moderna’s Recent Drop: 4 Reasons Bulls See Opportunity
    Via MarketBeat
    Exposures COVID-19 Product Safety
    Moderna, Tyson Foods And Adobe Are Among Top 10 Large Cap Stock Losers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
    Via Benzinga
    Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path?
    Via The Motley Fool
    Wall Street's Top 10 Stock Calls This Week - Saturday, Sept. 14
    Via Talk Markets
    Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More
    Via The Motley Fool
    After Moderna's Shocking News, Is the Stock a Buy or a Sell?
    Via The Motley Fool
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Moderna Faces Analyst Downgrades Amid Revised R&D Restructured Strategy and Delayed Profitability Target
    Via Benzinga
    Oracle To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Friday
    Via Benzinga
    Moderna's Pain Continues Amid Flurry Of Downgrades Following 'Tough' R&D Day
    Via Investor's Business Daily
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.